Shuttle Pharmaceuticals Holdings Past Earnings Performance
Past criteria checks 0/6
Shuttle Pharmaceuticals Holdings's earnings have been declining at an average annual rate of -36.2%, while the Biotechs industry saw earnings growing at 12.7% annually.
Key information
-36.2%
Earnings growth rate
-29.5%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | n/a |
| Return on equity | -162.6% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How Shuttle Pharmaceuticals Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -7 | 2 | 4 |
| 30 Sep 23 | 0 | -6 | 2 | 4 |
| 30 Jun 23 | 0 | -5 | 2 | 3 |
| 31 Mar 23 | 0 | -3 | 1 | 2 |
| 31 Dec 22 | 0 | -3 | 1 | 1 |
| 30 Sep 22 | 0 | -3 | 1 | 1 |
| 30 Jun 22 | 0 | -2 | 1 | 1 |
| 31 Mar 22 | 0 | -2 | 1 | 1 |
| 31 Dec 21 | 0 | -1 | 1 | 1 |
| 31 Dec 20 | 0 | -1 | 0 | 0 |
| 30 Jun 19 | 0 | -1 | 1 | 0 |
| 31 Mar 19 | 0 | -1 | 1 | 0 |
| 31 Dec 18 | 0 | -1 | 1 | 0 |
| 30 Sep 18 | 0 | 0 | 0 | 0 |
| 30 Jun 18 | 0 | 0 | 0 | 0 |
| 31 Mar 18 | 0 | 0 | 0 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
| 30 Sep 17 | 0 | 0 | 0 | 0 |
| 30 Jun 17 | 0 | 0 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 30 Sep 16 | 0 | 0 | 0 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
Quality Earnings: SHPH is currently unprofitable.
Growing Profit Margin: SHPH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SHPH is unprofitable, and losses have increased over the past 5 years at a rate of 36.2% per year.
Accelerating Growth: Unable to compare SHPH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SHPH is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: SHPH has a negative Return on Equity (-162.55%), as it is currently unprofitable.